The Report
“Acute Back Pain Global Clinical Trials Review, H1, 2014″ is now
available at lifescienceindustryresearch.com Contact sales@lifescienceindustryresearch.com with Report name in subject line and
your contact details to purchase this report or get your questions answered.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete Report is available @ http://www.lifescienceindustryresearch.com/acute-back-pain-global-clinical-trials-review-h1-2014.html .
Scope
- Data on the number of clinical
trials conducted in North America, South and Central America, Europe,
Middle-East and Africa and Asia-pacific and top five national
contributions in each, along with the clinical trial scenario in BRIC
nations
- Clinical trial (complete and in
progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials
(suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a
particular indication in a condensed manner
- Abridged view of the performance
of the trials in terms of their status, recruitment, location, sponsor
type and many more
- Obtain discontinued trial listing
for trials across the globe
- Espy the commercial landscape of
the major Universities / Institutes / Hospitals or Companies
Buy the
copy of this Report @ http://www.lifescienceindustryresearch.com/purchase?rname=15873 .
Acute Back Pain Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Back Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Back Pain Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Acute Back Pain Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Acute Back Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Back Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Acute Back Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Acute Back Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Acute Back Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Acute Back Pain Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Acute Back Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Acute Back Pain Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Acute Back Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Acute Back Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Acute Back Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Acute Back Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Acute Back Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 28
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Lincoln Pharmaceuticals Ltd, 2014* 29
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014* 30
Acute Back Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by DAEWON PHARM. CO.LTD., 2014* 31
Inquiry
before buying this Report @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=15873 . (Single
User License : US$ 2500 And Corporate User License : US$ 7500)
For
further information on “Acute Back Pain Global Clinical Trials Review, H1, 2014”
report Contact sales@lifescienceindustryresearch.com / Call +1 888 391 5441.